Global Neurotechnology Market Projected to Grow at 14.3% CAGR, Reaching $29.56 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Neurotechnology Industry Market Size Be by 2025?
The neurotechnology sector has experienced swift expansion lately, projected to advance from a valuation of $15.38 billion in 2024 to $17.34 billion the following year, reflecting a compound annual growth rate of 12.8%; this upward trajectory during the past period stems from heightened investment in research, a growing elderly demographic, the rising incidence of neurological conditions, favorable regulatory landscapes, and supportive governmental actions.

What's the Long-Term Growth Forecast for the Neurotechnology Market Size Through 2029?
Anticipation surrounds the neurotechnology sector, projecting substantial expansion in the imminent future, reaching a valuation of $29.56 billion by 2029, propelled by a compound annual growth rate (CAGR) soaring to 14.3%; this forthcoming surge is fundamentally driven by progress in regulatory frameworks, escalating prevalence of neurological conditions and genomic research, the increasing integration of telemedicine within neurological care, wider acceptance of personalized medicine approaches, and ongoing innovation in closed-loop system technologies, while key developments shaping this era encompass strides in neuroinformatics, the implementation of neuroplasticity-focused therapies, advancements in brain mapping projects, the rise of remote patient surveillance systems, and the proliferation of non-invasive brain stimulation techniques.

View the full report here:
https://www.thebusinessresearchcompany.com/report/neurotechnology-global-market-report

What Are the Key Growth Drivers Fueling the Neurotechnology Market Expansion?
Anticipated escalation in the occurrence of ailments affecting the nervous system is set to boost the expansion of the neurotechnology sector in the coming period.Neurological disorders, which involve any ailment or sickness impacting the brain, encompass frequently encountered issues such as Alzheimer's, Parkinson's, epileptic seizures, and debilitating migraines.Neurotechnology facilitates the identification and management of these neural ailments through diverse methodologies, including cerebral scanning technologies, methods of neural excitation, biofeedback training for the brain, and direct brain-computer links.To illustrate the scale, projections from the American Heart Association Inc., a US-based entity operating on a non-profit basis, indicated in January 2022 that the United States might see Alzheimer's disease and associated forms of dementia impacting 9.3 million individuals by the year 2060.Furthermore, data released in February 2023 by the World Health Organization (WHO), an international body headquartered in Switzerland, suggested an annual worldwide diagnosis rate of approximately 5 million new epilepsy cases.Consequently, the rising incidence rates associated with disorders of the nervous system serve as a primary catalyst for the future upward trend in the neurotechnology market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9840&type=smp

What Are the Key Trends Driving Neurotechnology Market Growth?
Innovation driven by technology is becoming a dominant force within the neurotechnology sector, compelling firms in this domain to integrate novel advancements to maintain their competitive standing. A prime illustration of this trend emerged in November 2022 when Blackrock Neurotech, a biotechnology firm situated in the United States, introduced Neuralace, their cutting-edge neurotechnology. This technology manifests as a filament thinner than an eyelash, capable of enveloping substantial portions of the brain's exterior surface; furthermore, the Neuralace system constitutes a flexible electrode boasting an extremely high channel count, offering a preview of the power behind forthcoming brain-computer interfaces, which ultimately aided individuals in recovering sensory perception like touch, enabling control over prosthetic limbs and digital apparatus.

How Is the Neurotechnology Market Segmented?
The neurotechnologymarket covered in this report is segmented -

1) By Conditions: Cognitive Disorders; Pain Treatment; Urinary And Faecal Incontinence; Epilepsy; Parkinson's Disease; Hearing Conditions; Sleep Disorder; Depression; Other Conditions
2) By Type: Imaging Modalities; Neurostimulation; Cranial Surface Measurement; Neurological Implants; Other Types
3) By End Use: Ambulatory Surgical Centers; Hospitals; Homecare Facilities; Other End Uses

Subsegments:
1) By Cognitive Disorders: Alzheimer's Disease; Attention Deficit Hyperactivity Disorder (ADHD); Dementia
2) By Pain Treatment: Chronic Pain; Neuropathic Pain; Acute Pain
3) By Urinary And Fecal Incontinence: Overactive Bladder; Neurogenic Bladder; Fecal Incontinence Management
4) By Epilepsy: Drug-Resistant Epilepsy; Seizure Management Devices
5) By Parkinson's Disease: Motor Symptoms Management; Non-Motor Symptoms Management
6) By Hearing Conditions: Tinnitus; Hearing Loss Solutions
7) By Sleep Disorder: Insomnia; Sleep Apnea; Restless Legs Syndrome
8) By Depression: Major Depressive Disorder; Treatment-Resistant Depression
9) By Other Conditions: Anxiety Disorders; Autism Spectrum Disorder; Traumatic Brain Injury (TBI)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9840&type=smp

Which Companies Are Leading the Charge in Neurotechnology Market Innovation?
Major companies operating in the neurotechnology market include General Electric, Medtronic PLC, Koninklijke Philips N.V., Shimadzu Corporation, EndoStim Inc., Elekta AB, Natus Medical Incorporated, Abbott, Boston Scientific Corporation, Cleveland Medical Devices Inc., Nihon Kohden Corporation, LivaNova PLC, Siemens Healthcare Private Limited, Hitachi Medical Corporation, Cochlear Limited, Advanced Bionics AG (Sonova), NeuroPace Inc., NeuroSigma Inc., NeuroMetrix Inc., NeuroSky Inc., NeuroVigil Inc., Neurotech Pharmaceuticals Inc., Neurotech International Limited, NeurotechEU, Neurotech Solutions, Neurotech Reports, Neurotech Research Development

Which Regions Are Leading the Global Neurotechnology Market in Revenue?
North America was the largest region in the neurotechnology market in 2024. Europe is expected to be the fastest-growing region in the neurotechnology market report during the forecast period. The regions covered in the neurotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9840

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.